Al Alaywa Khadija, Jouffroy Romain, Le Beller Christine, Rapalen Jean-Herlé, Lamhaut Lionel, Le Louet Agnes Lillo, Baud Frederic
UMR - 8257, Cognitive Action Group; University Paris Descartes, Paris, France.
Department of Anaesthesiology, Intensive Care Unit, SAMU de Paris, Necker Hospital Paris, APHP, Paris, France.
Turk J Anaesthesiol Reanim. 2020 Apr;48(2):148-155. doi: 10.5152/TJAR.2019.28003. Epub 2019 Oct 22.
Toxicological analysis (TA) is advised when assessing the prognosis and the treatment of drug overdose patients. Apart from this use, the value of TA has remained unclear. This study aimed at defining the value of TA regarding the toxicological diagnosis in severe overdose cases that involved addictive or recreational drugs (ARDs) that were used either alone or in combination with medicinal drugs.
The patients who were enrolled in the study had been admitted to our intensive care unit for the treatment of poisoning. TA was performed using advanced technologies such as mass spectrometry of blood/urine on admission. An occurrence indicated the supposed ingestion of a defined substance. Patients were included in a group depending on the combination of the occurrences of supposed ingested drugs (SID) and the results of the 1) TA: SID+, TA+; 2) SID+, not searched by TA; 3) SID-, TA+.
There were 224 occurrences of 90 substances in 70 patients. ARDs were present in 30 patients (43%). ARD accounted for 24 occurrences in the SID+, TA+ group, 10 occurrences in the SID+, not searched group and 196 occurrences in the SID-, TA+ group. In the SID+, TA+ group, 9 occurrences (69%) of ethanol were confirmed by TA. Ingestion of ethanol was invalidated in 4 occurrences (31%). In the patients who denied ethanol ingestion, TA confirmed the non-ingestion of ethanol using 30 blood measures (81%). Ethanol was involved in 57% of the patients, being the lone substance in only 1 case.
In drug overdose instances that result in organ failure(s) and involve ARDs, self-reporting is of limited value in assessing the patients' exposure to ARD. Multiple consumptions expose patients to unexpected drug interactions.
在评估药物过量患者的预后和治疗时,建议进行毒理学分析(TA)。除了这一用途外,TA的价值仍不明确。本研究旨在确定TA在涉及成瘾性或消遣性药物(ARDs)单独或与药用药物联合使用的严重过量病例的毒理学诊断中的价值。
纳入本研究的患者因中毒治疗入住我们的重症监护病房。入院时使用先进技术如血液/尿液质谱法进行TA。一次事件表明假定摄入了某种特定物质。根据假定摄入药物(SID)事件的组合以及1)TA的结果将患者分组:SID+,TA+;2)SID+,未进行TA检测;3)SID-,TA+。
70例患者中出现了90种物质的224次事件。30例患者(43%)存在ARDs。在SID+,TA+组中ARDs占24次事件,在SID+,未检测组中占10次事件,在SID-,TA+组中占196次事件。在SID+,TA+组中,TA确认了9次(69%)乙醇摄入事件。4次(31%)乙醇摄入事件被否定。在否认摄入乙醇的患者中,TA通过30次血液检测(81%)确认未摄入乙醇。57%的患者涉及乙醇,仅1例中乙醇为唯一物质。
在导致器官功能衰竭且涉及ARDs的药物过量情况下,自我报告在评估患者接触ARDs方面价值有限。多种药物的摄入使患者面临意外的药物相互作用。